Pediatric patients who adopted and sustained a CD exclusion diet achieved clinical remission and reported improvement in clinical symptoms and fecal calprotectin.

“When patients have a flare-up of Crohn’s, they can have anemia,” says William Sandborn, MD, the chief of gastroenterology and the director of the inflammatory bowel disease center at the ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

Crohn s disease is a chronic inflammatory disease of the gastrointestinal tract, mostly affecting the ileum. The inflammation can extend through the intestinal wall and tends to be asymmetric and ...

1 Chair of Gastroenterology, Department of Clinical and Experimental Pathology, University of ... Italy Diagnosis of intestinal Crohn's disease (CD) is challenging, since its signs/symptoms ...

Crohn's disease recurs after 'curative' surgery in ... [62] 1 Chair of Gastroenterology, Department of Clinical and Experimental Pathology, University of Udine School of Medicine, 33100 Udine ...

Further large-scale studies are needed to confirm the efficacy and safety of ustekinumab in managing paradoxical psoriasis and Crohn’s disease. Due to the insufficient investigation of the genetic ...

These datasets include high-resolution images of brain cancer and kidney disease (Lupus Nephritis), forming the cornerstone of the India Pathology Dataset (IPD) project. Histopathological images ...

In addition to conventional treatments, some people may use complementary and alternative medicine (CAM) to help manage Crohn’s disease symptoms. This can include the use of essential oils.

0:53 UBC researchers report breakthrough in Huntington treatment Scientists are unravelling the mystery of what triggers Huntington’s disease, a devastating and fatal hereditary disorder that ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's disease in adults. Omvoh targets interleukin ...